217 related articles for article (PubMed ID: 26785948)
1. Bcl-xL promotes metastasis independent of its anti-apoptotic activity.
Choi S; Chen Z; Tang LH; Fang Y; Shin SJ; Panarelli NC; Chen YT; Li Y; Jiang X; Du YN
Nat Commun; 2016 Jan; 7():10384. PubMed ID: 26785948
[TBL] [Abstract][Full Text] [Related]
2. CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation.
Liu Y; Clegg HV; Leslie PL; Di J; Tollini LA; He Y; Kim TH; Jin A; Graves LM; Zheng J; Zhang Y
Cell Death Differ; 2015 Jun; 22(6):1035-46. PubMed ID: 25476776
[TBL] [Abstract][Full Text] [Related]
3. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
4. Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion.
Du YC; Lewis BC; Hanahan D; Varmus H
PLoS Biol; 2007 Oct; 5(10):e276. PubMed ID: 17941720
[TBL] [Abstract][Full Text] [Related]
5. Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.
Keitel U; Scheel A; Thomale J; Halpape R; Kaulfuß S; Scheel C; Dobbelstein M
Oncotarget; 2014 Dec; 5(23):11778-91. PubMed ID: 25473892
[TBL] [Abstract][Full Text] [Related]
6. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL.
Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A
BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046
[TBL] [Abstract][Full Text] [Related]
7. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
[TBL] [Abstract][Full Text] [Related]
8. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
[TBL] [Abstract][Full Text] [Related]
9. Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer.
Zhang Y; Wang JH; Lu Q; Wang YJ
Oncol Rep; 2012 Jan; 27(1):109-13. PubMed ID: 21971866
[TBL] [Abstract][Full Text] [Related]
10. Role of phospholipase D2 in anti-apoptotic signaling through increased expressions of Bcl-2 and Bcl-xL.
Oh KJ; Lee SC; Choi HJ; Oh DY; Kim SC; Min do S; Kim JM; Lee KS; Han JS
J Cell Biochem; 2007 Aug; 101(6):1409-22. PubMed ID: 17541981
[TBL] [Abstract][Full Text] [Related]
11. Bcl-xL is an oncogenic driver in colorectal cancer.
Scherr AL; Gdynia G; Salou M; Radhakrishnan P; Duglova K; Heller A; Keim S; Kautz N; Jassowicz A; Elssner C; He YW; Jaeger D; Heikenwalder M; Schneider M; Weber A; Roth W; Schulze-Bergkamen H; Koehler BC
Cell Death Dis; 2016 Aug; 7(8):e2342. PubMed ID: 27537525
[TBL] [Abstract][Full Text] [Related]
12. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.
Castilla C; Congregado B; Chinchón D; Torrubia FJ; Japón MA; Sáez C
Endocrinology; 2006 Oct; 147(10):4960-7. PubMed ID: 16794010
[TBL] [Abstract][Full Text] [Related]
13. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
Fernández Y; España L; Mañas S; Fabra A; Sierra A
Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor ETS1 promotes apoptosis resistance of senescent cholangiocytes by epigenetically up-regulating the apoptosis suppressor BCL2L1.
O'Hara SP; Splinter PL; Trussoni CE; Guicciardi ME; Splinter NP; Al Suraih MS; Nasser-Ghodsi N; Stollenwerk D; Gores GJ; LaRusso NF
J Biol Chem; 2019 Dec; 294(49):18698-18713. PubMed ID: 31659122
[TBL] [Abstract][Full Text] [Related]
15. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
[TBL] [Abstract][Full Text] [Related]
17. BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
Weiler M; Bähr O; Hohlweg U; Naumann U; Rieger J; Huang H; Tabatabai G; Krell HW; Ohgaki H; Weller M; Wick W
Cell Death Differ; 2006 Jul; 13(7):1156-69. PubMed ID: 16254573
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
19. N'-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential.
Kamath PR; Sunil D; Ajees AA; Pai KS; Biswas S
Eur J Med Chem; 2016 Sep; 120():134-47. PubMed ID: 27187865
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
